The Uromigos

The Uromigos podcast, hosted by Tom Powles, professor of genitourinary oncology at Barts Cancer Centre, and Brian Rini, Ingram Professor of Medicine at Vanderbilt-Ingram Cancer Center, aims to broadcast the latest developments in GU cancer. Each episode features fascinating discussions with leading experts from around the world and dives into the data and clinical news relevant to the care of GU oncology patients. In their “Legends of GU Oncology” series, the podcasting duo focus on the founders of the field.

Articles by The Uromigos

The UromigosUromigos Live 2023 | November 20, 2023
Dr. Powles chaired a livestreamed RCC session that included lively discussion from Drs. Atkins, McDermott, and Rini.
View More
The UromigosUromigos Live 2023 | November 20, 2023
The panel highlights a serious of relevant studies in renal cell carcinoma, including CONTACT-03 and TiNivo-2.
The UromigosUromigos Live 2023 | November 20, 2023
The panel discusses data related to RLTs in prostate cancer, including a recap of the VISION trial and the PSMAfore trial.
The UromigosUromigos Live 2023 | November 20, 2023
The panel breaks down the details of the PROpel, TALAPRO-2, and MAGNITUDE trials along with relevant rPFS and HR data.
The UromigosUromigos Live 2023 | November 20, 2023
The panel discussed the latest updates in NMIBC, including relevant data pertaining to pembro, atezo, and more.
The UromigosUromigos Live 2023 | November 20, 2023
The panel discussed the latest data and updates in frontline bladder cancer during a livestreamed session.
The UromigosThe Uromigos | November 20, 2023
Tian Zhang joins the podcast to give an overview of some of the panels presented at this year's IKCS meeting.
The UromigosUromigos Live 2023 | November 8, 2023
In the final round of The Uromigos Cup, Team Cleveland battled Team LA to determine who would take home the coveted trophy.
The UromigosUromigos Live 2023 | November 8, 2023
The second round of The Uromigos Cup featured Team Cleveland versus Team NYC to see who would move on to the final round.
The UromigosUromigos Live 2023 | November 8, 2023
The first round of The Uromigos Cup featured Team Boston versus Team LA in genitourinary oncology-based trivia.
The UromigosThe Uromigos | November 14, 2023
Monty Pal, Toni Chouieri, and Tian Zhang join Tom and Brian to discuss CONTACT-03, TiNivo-2, IO-based therapy, and more.
The UromigosThe Uromigos | November 7, 2023
Brian is joined by Drs. Agarwal, Dorff, McKay, and Morris to review the state of radioligand therapy.
The UromigosThe Uromigos | November 6, 2023
Tom is joined by Drs. Chang, Daneshmand, and Grivas to discuss new therapies in NMIBC and BCG-refractory NMIBC.
The UromigosThe Uromigos | October 31, 2023
Silke Gillessen, MD, PhD recaps some of the kidney, bladder, and prostate cancer data from this year's ESMO meeting.
The UromigosThe Uromigos | October 31, 2023
Brian and Tom give details on the various panels that will take place at The Uromigos Live & Unplugged 2023.
The UromigosThe Uromigos | October 31, 2023
Dr. Kevin Kelly discusses the AMG509 phase 1 study of xaluritamig, a bispecific T cell engager, for prostate cancer.
The UromigosThe Uromigos | November 13, 2023
Xinan Sheng, MD, joins the podcast to discuss the RENOTORCH trial on toripalimab plus axitinib for advanced RCC.
The UromigosUromigos Live 2023 | October 26, 2023
Drs. McKay, Gupta, and more talk about the best moments from last year's Uromigos Live & Unplugged event.
The UromigosThe Uromigos | October 30, 2023
Michiel Van der Heijdan, MD, PhD, discusses EV-302 and CheckMate-901 on EV plus pembrolizumab and nivolumab plus ipilimumab.
The UromigosThe Uromigos | October 30, 2023
Yohann Loriot, MD, PhD, gives an update on the use of erdafitinib within the THOR randomized phase 3 trial.